Lobaplatin: a new antitumour platinum drug

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.1, 2001-01, pp. : 119-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Concepts in the Development of Platinum Antitumour Drugs: An Update

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-04 ,pp. : 187-198

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in antitumour platinum coordination compounds

By Momekov Georgi Momekova Denitsa

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 10, 2006-10 ,pp. : 1383-1403

Informa Healthcare

Access to resources Recommend Favorite

New platinum drug shows early promise in refractory cancers

Inpharma, Vol. 1, Iss. 1275, 2001-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Broadening the clinical use of platinum drug–based chemotherapy with new analogues

By Kelland Lloyd

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 1009-1021

Informa Healthcare

Access to resources Recommend Favorite

Novel Classes of Dimer Antitumour Drug Candidates

Current Pharmaceutical Design, Vol. 15, Iss. 6, 2009-02 ,pp. : 659-674

Bentham Science Publishers

Access to resources Recommend Favorite